Three-dimensional contrast-enhanced MR angiography

Topics in Magnetic Resonance Imaging

Volumn 8, Issue 6, 1996, Pages 322-344

  Maki, Jeffrey H ^a,b   Chenevert, Thomas L ^a   Prince, Martin R ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Contrast enhancement; Gadolinium enhanced MR angiography; MR angiography; MR imaging

Indexed keywords

GADOLINIUM CHELATE; GADOLINIUM PENTETATE ALBUMIN; GADOLINIUM PENTETATE DERIVATIVE; GADOLINIUM PENTETATE POLYLYSINE; SUPERPARAMAGNETIC IRON OXIDE; DIAGNOSTIC AGENT; GADOLINIUM;

AORTA ANEURYSM; AORTA DISSECTION; ARTIFACT; CAROTID ARTERY OBSTRUCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FLUOROSCOPY; FOURIER ANALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ARTERY STENOSIS; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MESENTERIC ARTERY OCCLUSION; PHLEBOGRAPHY; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; PULMONARY ARTERY; REVIEW; THREE DIMENSIONAL IMAGING; ARTICLE; IMAGE ENHANCEMENT; METHODOLOGY;

FOURIER ANALYSIS; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY;

EID: 0001221539     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-199612000-00002     Document Type: Review

References (71)

1. Prince MR. Body MR angiography with gadolinium contrast agents. MRI Clin North Am 1996;4(1):11-24.
2. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-64.
3. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Charcteristics of gadolinium-DTAP complex: a potential NMR contrast agent. AJR 1984;142:619-624.
4. Schima W, Mukerjee A, Saini S. Contrast-enhanced MR imaging. Clin Radiol 1996;51(4):235-44.
5. Goldstein HA, Kashanian FK, Blumetti RF, Holyoak WL, Hugo FP, Blumenfield DM. Safety assessment of gadopentetate dimeglumine in U.S. clinical trials. Radiology 1990;174:17-23.
6. Niendorf H, Haustein J, Alhassan A, Clauss W. Safety of gadolinium-DTPA: extended clinical experience. In: Brasch R, ed. Workshop on contrast-enhanced magnetic resonance, Napa, CA. Society for Magnetic Resonance in Medicine, 1991;70-79.
7. Haustein J, Niendorf HP, Krestin G, Louton T, Schuhmann-Giampieri G, Clauss W, Junge W. Renal tolerance of gadolinium-DTAP/dimeglumine in patients with chronic renal failure. Invest Radiol 1992;27:153-56.
8. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high dose gadolinium compared to iodinated contrast. J Magn Reson Imaging 1996;6:162-66.
9. Rofsky NM, Weinreb JC, Bosniak MA, Libes RB, Birnbaum BA. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991;180:85-89.
10. Hohenschuh E, Watson AD. Contrast Media: Theory and Mechanisms of Contrast-Enhancing Agents. In: Higgins CB, Hricak H, Helms CA, eds. Magnetic resonance imaging of the body, Philadelphia: Lippincott-Raven Publishers, 1997;1439-64.
11. Schmiedl U, Brasch RC, Ogan MD, Moseley ME. Albumin labeled with Gd-DTPA. Acta Radiol Suppl 1990;374:99-102.
12. Marchal G, Bosmans H, Van Hecke P, Speck U, Aerts P, Vanhoenacker P, Baert AL. MR angiography with Gadopentetate Dimeglumine-polylysine: evaluation in rabbits. AJR 1990;155:407-11.
13. Bogdanov AA, Weissleder R, Frank HW, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993;187:701-06.
14. Loubeyre P, Canet E, Zhao S, Benderbous S, Amiel M, Revel D. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits. Invest Radiol 1996;31(5):288-93.
15. Saini S, Edelman RR, Sharma P, et al. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). AJR 1995;164:1147-52.
16. Anzai Y, Prince MR, Chenevert TL, Maki JG, Londy F, London M, McLachlan SJ. MR angiography with and ultrasmall superparamagnetic iron oxide blood pool agent. JMRI 1997;7:209-14.
17. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992;183:1-11.
18. Grist TM, Korosec FR, Peters DC, Walovitch RC, Yucel EK, Mistretta CA. Steady state and dynamic MR angiographic imaging with MS-325: initial experience in humans. Fifth Scientific Meeting and Exhibition. Vancouver, BC, Canada: International Society for Magnetic Resonance in Medicine, 1997; 207.
19. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. AJR 1996;166:73-77.
20. Benderbous S, Bonnemain B. Supermagnetic nanoparticles as blood-pool contrast agents. Radiologie 1995(suppl 2)35:S248-52.
21. Schmield U, Sievers RE, Brasch RC, et al. Acute myocardial ischemia and reperfusion: MR imaging with albumin-Gd-DTPA. Radiology 1989;170:351-56.
22. Saeed M, Wendland M, Masui T, Connolly AJ, Derugin N, Brasch RC, Higgins CB. Myocardial infarction: assessment with an intravascular MR contrast medium. Work in progress. Radiology 1991;180:153-60.
23. Berthezene Y, Vexler V, Jerome H, Sievers RE, Moseley ME, Brasch RC. Differentiation of capillary leak and hydrostatic pulmonary edema with a macromolecular MR imaging contrast agent. Radiology 1991;181:773-77.
24. Baxter AB, Melnikoff S, Stites DP, Brasch RC. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging: induction and characterization of antibodies in animals. Invest Radiol 1991;26:1035-40.
25. Van Hecke P, Marchal G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991;9:313-21.
26. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. JMRI 1994;4:301-07.
27. Ehman RL, Revel D, Sievers R, Brasch RC, McNamara MT, Higgins CB. Acute myocardial ischemia. Magnetic resonance contrast enhancement with gadolinium-DTPA. Radiology 1984;153:157-63.
28. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arterography. JMRI 1993;3:877-81.
29. Runge VM, Kirsch JE, Lee C. Contrast-enhance MR angiography. JMRI 1993;3:233-239.
30. Holland GA, Dougherty L, Carpenter JP, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. AJR 1996;166:971-81.
31. Moseley ME, Sawyer AM. Imaging Techniques: Pulse Sequences. In: Higgins, C. B., Hricak, H., Helms, C. A., eds. Magnetic resonance imaging of the body, Philadelphia: Lippincott-Raven Publishers, 1997;43-69.
32. Wehrli FW. Principles of Magnetic Resonance. In: Stark, D. D., Bradley, W. G., eds. Magnetic Resonance Imaging. St. Louis: Mosby-Year Book Publishers, 1992;3-20.
33. Prince MR, Narasimham DL, Stanley JC, Chenevert TL, Williams DM, Marx MV, Cho KJ. Breath hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-92.
34. Snidow JJ, Johnson MS, Harris VJ, et al. Three-dimensional gadolinium-enhanced MR angiography for aortoiliac inflow assessment plus renal artery screening in a single breath hold. Radiology 1996;198:725-32.
35. Leung DA, McKinnon GC, Davis CP, Pfammatter T, Krestin GP, Debatin JF. Breath-hold, contrast-enhanced, three-dimensional MR angiography. Radiology 1996;200:569-71.
36. Hendrick RE, Roff U. Image contrast and noise. In: Stark DD, Bradley WG., eds. Magnetic Resonance Imaging. Chicago, IL: Mosby-Year Book, 1991;135.
37. Weinmann HJ, Laniado M, Mützel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-72.
38. Maki JH, Prince MR, Londy FJ, Chenevert TL. The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality. JMRI 1996;6:642-51.
39. Riederer SJ, Tasciyan T, Farzaneh F, Lee JN, Wright RC, Herfkens RJ. MR flouroscopy: technical feasibility. Magn Reson Med 1988;8:1-15.
40. Bampton AEH, Riederer SJ, Korin HW. Centric phase-encoding order in three-dimensional MP-RAGE sequences: application to abdominal imaging. JMRI 1992;2:327-34.
41. Wilman AH, Riederer SJ. Improved centric phase encoding orders for three-dimensional magnetization-prepared MR angiography. Magn Reson Med 1996;36:384-92.
42. Wilman AH, Riederer SJ, Breen JF, Ehman RL. Elliptical spiral phase-encoding order: an optimal, field-of-view-dependent ordering scheme for breath-hold contrast-enhanced 3D MR angiography. Radiology 1996:210(P):328-29.
43. Maki JH, Prince MR, Chenevert TL. The effects of incomplete breath holding on 3D MR image quality. JMRI; in press.
44. Snidow JJ, Aisen AM, Harris VJ, Trerotola SO, Johnson MS, Sawchuk AP, Dalsing MC. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995;196:371-78.
45. Steiner P, Debatin JF, Romanowski B, Hany TF, McKinnon GD. Optimization of breath-hold 3D MR pulmonary angiography. Radiology 1996;201(P):201.
46. Hany TF, Debatin JF, Schmidt M, McKinnon GC, Krestin GP, Pfammatter T. Three-dimensional MR angiography of the renal arteries in a single breath-hold. Radiology 1996;201(P):218.
47. Prince MR, Grist TM, Debatin JF. 3D Contrast MR Angiography. Berlin: Springer-Verlag Publishers, 1997;16-17.
48. Strouse PJ, Prince MR, Chenevert TL. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns. Radiology 1996;201:809-16.
49. Prince MR, Chenevert TL, Foo TK, Londy FJ, Ward JS, Maki JH. Contrast-enhanced abdominal MR angiography: optimization of imaging delay time by automating the detection contrast material arrival in the aorta. Radiology 1997;203:109-14.
50. Earls JP, Rofsky NM, DeCorato DR, Krinsky GA, Weinreb JC. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996;201:705-10.
51. Krinsky G, Rofsky N, Flyer M, et al. Gadolinium-enhanced three-dimensional MR angiography of acquired arch vessel disease. AJR 1996;167(4):981-987.
52. Foo TKF, Manojkumar S, Prince MR, Chenevert TL. Automated detection of bolus arrival and initiation of data acquisition in fast, three-dimensional, gadolinium-enhanced MR angiography. Radiology 1997;203:275-80.
53. Wilman AH, Debbins JP, Rossman PJ, et al. Flouroscopically-triggered contrast-enhanced three dimensional MR angiography. Accepted for presentation at the Fifth Scientific Meeting and Exhibition. Vancouver, Canada: International Society for Magnetic Resonance in Medicine, 1997.
54. Levy RA, Maki JH. 3D contrast enhanced MRA of the extracranial carotid arteries. Neuroradiol; accepted pending revision.
55. Korosec FR, Grist TM, Frayne R, Polzin JA, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Fourth Scientific Meeting and Exhibition. New York, NY: International Society for Magnetic Resonance in Medicine, 1996;238.
56. Korosec FR, Grist TM, Frayne R, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;36:345-351.
57. Mistretta CA, Grist TM, Frayne R, Korosec FR. Contrast and motion artifacts in 4D MR angiography. Radiology 1996;201(P):238.
58. Wood ML, Runge VM, Henkelman RM. Overcoming Motion in Abdominal MR Imaging. AJR 1988;150(3):513-522.
59. Ehman RL, Felmlee JP. Adaptive Technique for High-Definition MR Imaging of Moving Structure. Radiology 1989;173(1):255-263.
60. Du YP, Parker DL, Davis WL, Cao T. Reduction of partial-volume artifacts with zero-filled interpolation in three-dimentional MR angiography. J Magn Reson 1994;4:733-741.
61. Ros PR, Gauger J, Stoupis C, et al. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate. AJR 1995;165:1447-1451.
62. Saloner D. MRA: Principles and Display. In: Higgins CB, Hricak H, Helms CA, eds. Magnetic Resonance Imaging of the Body. Philadelphia: Lippincott-Raven Publishers, 1997;1345-68.
63. Prince MR, Grist TM, Debatin JF. 3D Contrast MR Angiography. Berlin: Springer-Verlag Publishers, 1997;26-27.
64. Laub G. Displays for MR angiography. Magn Reson Med 1990;14:222-29.
65. Rossnick S, Laub G, Braeckle R. Three dimensional display of blood vessels in MRI. Proceedings of the IEEE: computers in cardiology. New York: IEEE, 1986:193-95.
66. Anderson C, Saloner D, Tsuruda J, Shapeero L, Lee R. Artifacts in maximum intensity projection display of MR angiograms. AJR 1990;154:623-29.
67. Douek PC, Revel D, Chazel S, Falise B, Villard J, Amiel M. Fast MR angiography of the aortoiliac arteries and arteries of the lower extremity: value of bolus-enhanced, whole-volume subtraction technique. AJR 1995;165:431-37.
68. Lee VS, Flyer MA, Weinreb JC, Krinsky GA, Rofsky NM. Image subtraction in gadolinium-enhanced MR imaging. AJR 1996;167:1427-32.
69. Wang Y, Johnston DL, Breen JF, et al. Dynamic MR digital subtraction angiography using contrast enhancement, fast data acquisition, and complex subtraction. Magn Reson Med 1996;36:551-56.
70. Prince MR, Shoenberg SO, Ward JS, Londy FJ, Wakefield TW, Stanley JC. MR features of hemodynamically and functionally significant atherosclerotic renal artery stenosis. Radiology; accepted pending review.
71. Ho KY, Leiner T, de Haan MH, van Engelshoven JMA. Gadolinium optimized tracking technique: a new MRA technique for imaging the peripheral vascular tree from aorta to the foot using one bolus of gadolinium. Fifth Scientific Meeting and Exhibition. Vancouver, BC, Canada: International Society for Magnetic Resonance in Medicine, 1997;203.